Skip to main content
H.R. 7050 119th Congress House

Homeopathic Drug Product Safety, Quality, and Transparency Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act with respect to homeopathic drug products, and for other purposes.

Introduced: January 14, 2026 Introduced by: Pete Sessions Republican · Texas See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 14, 2026
Referred to the House Committee on Energy and Commerce.
Jan 14, 2026
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now January 14, 2026

Referred to the House Committee on Energy and Commerce.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 4

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • VENABLE LLP
    for AMERICANS FOR HOMEOPATHY CHOICE ACTION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
  • VENABLE LLP
    for AMERICANS FOR HOMEOPATHY CHOICE ACTION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
  • CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY
    for CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY · New York · 1st Quarter 2026 (Jan 1 - Mar 31)
  • VENABLE LLP
    for AMERICANS FOR HOMEOPATHY CHOICE ACTION · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7050: Homeopathic Drug Product Safety, Quality, and Transparency Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-7050/
MLA
"H.R. 7050: Homeopathic Drug Product Safety, Quality, and Transparency Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-7050/.
Bluebook (legal)
H.R. 7050, 119th Cong. (2026), https://openamerica.io/bill/119-HR-7050/.
Markdown link
[H.R. 7050: Homeopathic Drug Product Safety, Quality, and Transparency Act](https://openamerica.io/bill/119-HR-7050/)
Report a problem